These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
182 related items for PubMed ID: 4698011
1. [New methods for measurement of the tremor and rigidity in patients with Parkinson's disease treated with L-Dopa]. Paci A, Freddi A, Barba C. Riv Neurol; 1973; 43(1):15-39. PubMed ID: 4698011 [No Abstract] [Full Text] [Related]
3. [Monosynaptic reflex in patients with Parkinson's disease treated with L-dopa]. Palao Sánchez A. Arch Neurobiol (Madr); 1974; 37(1):1-10. PubMed ID: 4838663 [No Abstract] [Full Text] [Related]
4. [L-dopa effect in Parkinson's syndrome]. Römer F, Bettag W, Bock WJ. Z Allgemeinmed; 1971 Feb 28; 47(6):281-3. PubMed ID: 5571715 [No Abstract] [Full Text] [Related]
5. Influence of L-dopa on the EEG and EMG in Parkinson patients. Visser SL, Postma JU. Psychiatr Neurol Neurochir; 1971 Feb 28; 74(4):315-21. PubMed ID: 5146237 [No Abstract] [Full Text] [Related]
6. [Efficacy and side effects of L-dopa in patients with Parkinson's syndrome]. Lombardo L. Arch Invest Med (Mex); 1973 Feb 28; 4(3):215-24. PubMed ID: 4784173 [No Abstract] [Full Text] [Related]
10. [Disulfiram and L-dopa in patients with Parkinson's syndrome and in torsion dystonia]. Serrano PA, Irigoyen M. Prensa Med Mex; 1972 Apr 28; 37(7):246-50. PubMed ID: 4646433 [No Abstract] [Full Text] [Related]
11. The role of a dihydromorphanthridine derivative in Parkinson's patients treated with L-dopa. A preliminary report. Wycis HT. Confin Neurol; 1972 Apr 28; 34(1):130-5. PubMed ID: 5084387 [No Abstract] [Full Text] [Related]
12. [Silent period in patients with Parkinson's disease treated with L-Dopa]. Palao Sánchez A. Arch Neurobiol (Madr); 1973 Apr 28; 36(1):47-56. PubMed ID: 4706780 [No Abstract] [Full Text] [Related]
13. L-dopa therapy in Parkinson's disease. Lipman IJ. Va Med Mon (1918); 1971 May 28; 98(5):242-8. PubMed ID: 4931138 [No Abstract] [Full Text] [Related]
15. [L-Dopa in the treatment of Parkinson's disease. (Considerations on 51 cases)]. Mazza C, Buffatti PF, Bazzan A, Lion P. Fracastoro; 1970 May 28; 63(5):768-73. PubMed ID: 5519378 [No Abstract] [Full Text] [Related]
16. Quantitative measurements of L-dopa therapy in Parkinson's disease. Webster DD. Trans Am Neurol Assoc; 1969 May 28; 94():348-50. PubMed ID: 5374483 [No Abstract] [Full Text] [Related]
17. [Current treatment of Parkinson syndrome with L-dopa]. Gerstendbrand F, Gründig E, Musiol A. Pol Tyg Lek; 1972 May 22; 27(21):798-800. PubMed ID: 4555002 [No Abstract] [Full Text] [Related]
18. [Treatment of Parkinson's disease with L-dopa. 77 cases]. Boudin G, Castaigne P, Lhermitte F, Beck H, Guillard A, Marteau R, Pepin B, Rondot P, Raphy B. Rev Neurol (Paris); 1970 Feb 22; 122(2):89-102. PubMed ID: 4931719 [No Abstract] [Full Text] [Related]
19. [L-Dopa in Parkinson's-syndrome. New therapeutic attack?]. Brockmann AW. Ther Ggw; 1970 Nov 22; 109(11):1590-3. PubMed ID: 5486128 [No Abstract] [Full Text] [Related]
20. [Utility of L-dopa in the treatment of Parkinson's disease and parkinsonism-like diseases]. Herskovits E, Matera R, Gacitua EF. Medicina (B Aires); 1972 Nov 22; 32(1):10-4. PubMed ID: 5019629 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]